Cachexia: pathophysiology and clinical relevance

被引:553
作者
Morley, JE
Thomas, DR
Wilson, MMG
机构
[1] St Louis Univ, Sch Med, Div Geriatr Med, St Louis, MO 63104 USA
[2] GRECC, VA Med Ctr, St Louis, MO USA
关键词
cachexia; pathogenesis; sarcopenia; weight loss;
D O I
10.1093/ajcn/83.4.735
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Cachexia causes weight loss and increased mortality. It affects more than 5 million persons in the United States. Other causes of weight loss include anorexia, sarcopenia, and dehydration. The pathophysiology of cachexia is reviewed in this article. The major cause appears to be cytokine excess. Other potential mediators include testosterone and insulin-like growth factor I deficiency, excess myostatin, and excess glucocorticoids. Numerous diseases can result in cachexia, each by a slightly different mechanism. Both nutritional support and orexigenic agents play a role in the management of cachexia.
引用
收藏
页码:735 / 743
页数:9
相关论文
共 143 条
[1]   Outcome of percutaneous endoscopic gastrostomy (PEG): comparison of two policies in a 4-year experience [J].
Abuksis, G ;
Mor, M ;
Plaut, S ;
Fraser, G ;
Niv, Y .
CLINICAL NUTRITION, 2004, 23 (03) :341-346
[2]   Cancer cachexia is regulated by selective targeting of skeletal muscle gene products [J].
Acharyya, S ;
Ladner, KJ ;
Nelsen, LL ;
Damrauer, J ;
Reiser, PJ ;
Swoap, S ;
Guttridge, DC .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (03) :370-378
[3]   NF-κB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight [J].
Agustí, A ;
Morlá, M ;
Sauleda, J ;
Saus, C ;
Busquets, X .
THORAX, 2004, 59 (06) :483-487
[4]  
Allen NE, 2002, CANCER EPIDEM BIOMAR, V11, P1441
[5]   Inflammatory mediators in chronic heart failure: An overview [J].
Anker, SD ;
von Haehling, S .
HEART, 2004, 90 (04) :464-470
[6]   Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure [J].
Anker, SD ;
Ponikowski, PP ;
Clark, AL ;
Leyva, F ;
Rauchhaus, M ;
Kemp, M ;
Teixeira, MM ;
Hellewell, PG ;
Hooper, J ;
Poole-Wilson, PA ;
Coats, AJS .
EUROPEAN HEART JOURNAL, 1999, 20 (09) :683-693
[7]   Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study [J].
Anker, SD ;
Negassa, A ;
Coats, AJS ;
Afzal, R ;
Poole-Wilson, PA ;
Cohn, JN ;
Yusuf, S .
LANCET, 2003, 361 (9363) :1077-1083
[8]  
ANKER SD, 2000, DIAL CARDIOVASC MED, V5, P162
[9]   The pharmacological treatment of cachexia [J].
Argilés, JM ;
Almendro, V ;
Busquets, S ;
López-Soriano, FJ .
CURRENT DRUG TARGETS, 2004, 5 (03) :265-277
[10]   Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice [J].
Barton, ER ;
Morris, L ;
Musaro, A ;
Rosenthal, N ;
Sweeney, HL .
JOURNAL OF CELL BIOLOGY, 2002, 157 (01) :137-147